辉凌制药（中国）有限公司

Chinese company of Ferring Pharmaceuticals, the Swiss-headquartered privately owned biopharmaceutical group founded in Sweden in 1950. Manufactures and markets Ferring's medicines in China with a portfolio concentrated in reproductive medicine and maternal health, urology, gastroenterology and endocrinology, and runs local clinical and regulatory operations alongside its Chinese production site.